Vidur Bhalla

Vidur Bhalla practices at Saint Luke's Hospital of Kansas City in Kansas City, Missouri, part of BJC Health.

Vidur Bhalla's NPI, 1144586124, was assigned on April 4, 2012. Vidur Bhalla graduated from Loyola University of Chicago, Stritch School of Medicine in 2012. Vidur Bhalla holds Missouri license 2017022363.

Vidur Bhalla's primary practice is Saint Luke's Hospital of Kansas City, at 4401 Wornall Road, Kansas City, MO 64111 in Jackson County. The practice phone is (816) 932-2000.

Vidur Bhalla's primary practice is Saint Luke's Hospital of Kansas City in Kansas City, Missouri, part of BJC Health. Vidur Bhalla is also affiliated with The University of Kansas Hospital. The medical group on file is Saint Luke's Medical Group. Dmand AI also links Vidur Bhalla to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vidur Bhalla practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Vidur Bhalla's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Vidur Bhalla's licenses on file in 2 states: Missouri and Illinois.

CMS data shows 534 Medicare services from Vidur Bhalla across 9 procedure codes in 2024, for 204 Medicare patients. Medicare paid $66,301 for them.

CMS counts 204 Medicare patients who saw Vidur Bhalla in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vidur Bhalla's median patient age at 67, with 48% women.

In 2024, Vidur Bhalla wrote 820 Medicare Part D claims for 252 patients. 97% of them were for generic drugs. CMS names the drug for 735 of them, across 13 drugs with 11 or more claims each, at $76,002 in total drug cost. In 2023, CMS named 671 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Vidur Bhalla for performance year 2024, reported as part of a group. Vidur Bhalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vidur Bhalla as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Vidur Bhalla, published from 2012 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Endoscopy, Tomography, X-Ray Computed and Cerebrospinal Fluid Leak. Vidur Bhalla has published most often in Int Forum Allergy Rhinol. Vidur Bhalla's most frequent co-authors are Alexander G. Chiu, MD, Brian Craig Rodgers, MD and Sameer Ahmed Alvi, MD.

CMS Open Payments shows 33 general payments to Vidur Bhalla from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $1,666.

Vidur Bhalla graduated from Loyola University of Chicago, Stritch School of Medicine in 2012.